Editors' note: Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
In “Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance,” Fonseca et al. reported a higher frequency of cardiomyopathies identified on cardiac MRI in patients with ischemic stroke than in the general population, particularly among patients with stroke of undetermined etiology. Lattanzi and Silvestrini commended the authors' contribution to our understanding of embolic strokes of undetermined source (ESUS). To learn more about this patient population, Lattanzi and Silvestrini recommended a thorough review of data on demographics, stroke severity, and location and evaluation for embolic sources in patients with ESUS to assess for the presence of unique phenotypes that would benefit from specific diagnostic algorithms and therapeutic approaches. Fonseca and Ferro agreed with the need for further evaluation of this patient population and, based on their findings, recommended increased use of cardiac MRI. However, they noted that it is not feasible to do this for all patients with ESUS and acknowledged the need to clarify which patients would benefit from it the most.
In “Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonance,” Fonseca et al. reported a higher frequency of cardiomyopathies identified on cardiac MRI in patients with ischemic stroke than in the general population, particularly among patients with stroke of undetermined etiology. Lattanzi and Silvestrini commended the authors' contribution to our understanding of embolic strokes of undetermined source (ESUS). To learn more about this patient population, Lattanzi and Silvestrini recommended a thorough review of data on demographics, stroke severity, and location and evaluation for embolic sources in patients with ESUS to assess for the presence of unique phenotypes that would benefit from specific diagnostic algorithms and therapeutic approaches. Fonseca and Ferro agreed with the need for further evaluation of this patient population and, based on their findings, recommended increased use of cardiac MRI. However, they noted that it is not feasible to do this for all patients with ESUS and acknowledged the need to clarify which patients would benefit from it the most.
Footnotes
Author disclosures are available upon request (journal{at}neurology.org).
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Dr. Dennis Bourdette and Dr. Lindsey Wooliscroft
► Watch
Related Articles
Alert Me
Recommended articles
-
Article
Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonanceAna Catarina Fonseca, João Pedro Marto, Daniela Pimenta et al.Neurology, December 02, 2019 -
Article
Embolic stroke of undetermined source correlates to atrial fibrosis without atrial fibrillationKarman Tandon, David Tirschwell, W.T. Longstreth, Jr et al.Neurology, June 25, 2019 -
Article
The value of transesophageal echocardiography for embolic strokes of undetermined sourceAristeidis H. Katsanos, Rohini Bhole, Alexandra Frogoudaki et al.Neurology, August 03, 2016 -
Disputes & Debates: Editors' Choice
Reader response: Undetermined stroke genesis and hidden cardiomyopathies determined by cardiac magnetic resonanceSimona Lattanzi, Mauro Silvestrini et al.Neurology, November 16, 2020